Overview

Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis

Status:
Completed
Trial end date:
1996-08-01
Target enrollment:
Participant gender:
Summary
OBJECTIVE: I. Evaluate the efficacy of fluconazole in patients with lymphocutaneous or visceral sporotrichosis.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
University of Alabama at Birmingham
Treatments:
Fluconazole